|LETTERS TO THE EDITOR - LETTER IN RESPONSE TO PREVIOUSLY PUBLISHED ARTICLES
|Year : 2018 | Volume
| Issue : 3 | Page : 310
Nagaraju Umashankar1, Belliappa Pemmanda1, P Gopkumar2, AJ Hemalatha3, KS Priya1, HV Prashanth4
1 Department of Dermatology, Rajarajeshwari Medical College and Hospitals, Tumkur, Karnataka, India
2 Department of Quality Assurance, GRY Institute of Pharmacy, Khargone, Madhya Pradesh, India
3 Department of Preventive Medicine, Oxford Institute of Medical Sciences and Research Centre Bengaluru, Tumkur, Karnataka, India
4 Department of Microbiology, Sri Siddhartha Medical College, Tumkur, Karnataka, India
|Date of Web Publication||04-Apr-2018|
Dr. Nagaraju Umashankar
Department of Dermatology, Rajarajeshwari Medical College and Hospital, Mysore Road, Bengaluru - 560 074, Karnataka
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Umashankar N, Pemmanda B, Gopkumar P, Hemalatha A J, Priya K S, Prashanth H V. Authors' reply. Indian J Dermatol Venereol Leprol 2018;84:310
|How to cite this URL:|
Umashankar N, Pemmanda B, Gopkumar P, Hemalatha A J, Priya K S, Prashanth H V. Authors' reply. Indian J Dermatol Venereol Leprol [serial online] 2018 [cited 2020 Jun 6];84:310. Available from: http://www.ijdvl.com/text.asp?2018/84/3/310/229300
We appreciate the queries raised by the correspondent on our article “Effectiveness of topical green tea against multidrug resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial” published in the March-April (2018) issue of the journal.
Kindly find our replies below on each point.
| Study Subjects|| |
Multidrug resistance was an incidental finding and was not included in our inclusion criteria. As multidrug resistant strains were seen in 89.1% participants in the green tea group and 81.1% in the placebo group, we included this in the title.
| Sample Size Calculation|| |
The first part of the study was a cross-sectional study to identify the cases among school children; later, the identified cases were administered the intervention. Hence, sample size calculation was done using the same formula.
| Randomization|| |
We agree with the comments, but since this was an open label clinical trial, not much emphasis was given on randomization.
| Blinding|| |
This was mentioned in the 'limitations' section.
| Statistical Methods Used|| |
It is true that means of continuous variables, such as age and duration of lesion, cannot be compared; this was not done in our study. However, for your information, it was only compared for gender (categorical nominal variable) and P value was calculated, which is mentioned below in the table.
| Ethical Issues|| |
Informed consent was taken from the parents. Assent forms were also obtained.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.